Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:44 PM
Ignite Modification Date:
2025-12-24 @ 7:44 PM
NCT ID:
NCT04057703
Eligibility Criteria:
Inclusion Criteria:
* Patient initiating a first second-line immunomodulatory treatment (azathioprine, ciclosporine, eltrombopag, hydroxychloroquine, mycophénolate mofétil, rituximab, romiplostim), registered in the OBS'CEREVANCE database, presenting a Chronic Immune-Thrombocytopenic Purpura, Autoimmune Hemolytic Anemia or simultaneous EVANS syndrome.
Exclusion Criteria:
* Patient under immunosuppressant for another immunological pathology at the initiation of the first second line treatment,
* Patient treated with 2 second-line treatments on the same day,
* Oral refusal of participation of the patient or his legal representatives, after reading the information note specific for the study.
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
18 Years
Study:
NCT04057703
Study Brief:
Protocol Section:
NCT04057703